May 4 Quick Takes: Following Lyra’s success, Ayala readies for NASDAQ IPO; plus Medable and Hyloris

By Robin Sawka, BioCentury Staff | May 5, 2020 | 1:28 AM GMT

Ayala sets IPO terms
Ayala Pharmaceuticals Inc., which develops small molecules for cancer, proposed to sell 3.3

Read the full 166 word article

How to gain access

Continue reading with a
two-week free trial.